by Eddie Bishop | Feb 3, 2023 | EPO
Background Historically (pre-2019), a subrange was considered novel over the prior art if the following criteria were met (T198/84 and T279/89): a) The selected subrange is narrower than the known range; b) The selected subrange is sufficiently far removed from any...
by Alex Bajjon | Jul 7, 2022 | US & International
Excess Claims Fees Up until now, there have been no excess claims fees in Canada and therefore minimal or no incentives for applicants to limit the number of claims in their patent applications. Under the new regime, excess claims fees will be payable for claim sets...
by Sean Hutchinson | May 31, 2022 | Trademarks
Background In 2021, both Luxembourg’s Tribunal d’arrondissement and Belgium’s Tribunal de l’entreprise francophone de Bruxelles referred cases to the CJEU as Case C-148/21 and Case C 184/21, respectively. These referrals asked the CJEU to decide whether the operator...
by Vicky Colley | May 10, 2022 | News
Juliette joined us in 2013 as a Chartered Patent Attorney and has a wide range of experience in drafting and prosecuting chemical, biochemical and mechanical device patents. In her specialist field of organic chemistry she represents our chemical and pharmaceutical...
by Eddie Bishop | Apr 25, 2022 | US & International
Questions on the European SPC Regulation, in particular in relation to SPCs for combination products, have been raised at the CJEU many times over the years. It is therefore hoped that this newest referral may provide some much-needed clarity. Background For an SPC to...
Recent Comments